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Abstract: Background: This study aimed to test the validity of three different submaximal tests
(i.e., 3-min step test with 20.3-cm step box height (3MST20), 3-min step test with 30-cm step
box height (3MST30), and 6-min walk test (6MWT)) in estimating maximal oxygen consumption
(VO2max) in young and healthy individuals. Methods: The 3MST20, 3MST30, 6MWT, as well as the
cardiopulmonary exercise test (CPET) were performed in 73 participants (37 men and 36 women;
mean age: 30.8 ± 9.3 years). All participants visited the clinic three times in a random order
for anthropometric measurements, three submaximal tests, and the VO2max test. Multiple linear
regression analyses were conducted to construct the VO2max prediction equations for each submaximal
test. Results: The prediction equations developed based on multiple regression analyses for each
submaximal tests were as follows: 3MST20: VO2max = 86.0 − 10.9 × sex (male = 1, female = 2) − 0.4 ×
age − 0.1 × weight − 0.1 × heart rate recovery at 30 s (HRR30s); 3MST30: VO2max = 84.5 − 10.2 × sex
(male = 1, female = 2) − 0.4 × age − 0.1 × weight − 0.1 × HRR30s; and 6MWT: VO2max = 61.1 − 11.1 ×
sex (male = 1, female = 2) − 0.4 × age − 0.2 × weight − 0.2 × (distance walked·10−1). The estimated
VO2max values based on formulated equations were 37.0± 7.9, 37.3± 7.6, and 36.9± 7.9 mL·kg−1·min−1
derived from the 3MST20, 3MST30, and 6MWT, respectively. These estimated VO2max values were not
significantly different from the measured VO2max value, 37.3 mL·kg−1·min−1. The estimated VO2max
based on the 3MST20, 3MST30, and 6MWT results explained 73.4%, 72.2%, and 74.4% of the variances
in the measured VO2max (p < 0.001), respectively. Conclusions: The 3MST20, 3MST30, and 6MWT were
valid in estimating VO2max in relatively young and healthy Asian individuals.
Keywords: step test; 6-min walk test; validation; fitness
1. Introduction
Cardiopulmonary fitness has been used as an index of aerobic fitness for several decades [1].
However, direct measurement of cardiopulmonary fitness using gas analyzers can be costly and
sometimes unsafe. Thus, indirect measurement has been considered using a step box [2], cycle
ergometer [3], and treadmill [4,5]. Since the use of large equipment such as a cycle ergometer and
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treadmill could be difficult for field tests, various step tests have been developed and used as a
surrogate method to estimate maximal oxygen consumption (VO2max) [6].
There are two different types of step tests: Incremental multi-stage and single-stage step tests [4].
In incremental step tests, either the step box height or stepping rate is increased in an incremental
manner [7], and various responses of participants during and after exercise are used to estimate
VO2max [8–10]. Although incremental step tests consider more variables such as heart rate responses,
stepping rate or step height reached, and rate of perceived exertion (RPE) which is related to the
participants’ aerobic capacity, incremental step tests generally take a longer duration and elicit more
physical stress [8–10]. Conversely, single-stage step tests mostly take a shorter duration and also only
use heart rate recovery to estimate VO2max [7]. Among single-stage step tests, the Tecumseh step test
(3-min step test using 20.3-cm step box height (3MST20)) [6] and the YMCA 3-min step test (3-min
step test using 30-cm step box height (3MST30)) [2] have been used widely. Since the 3MST30 uses a
higher step box height, local muscle fatigue and joint pain could be limiting factors in the elderly and
participants with very low fitness levels or poor joint conditions [2,11]. Thus, it would be valuable to
understand whether the 3MST20 is as good as the 3MST30 in estimating VO2max.
In addition to step tests, the 6-min walk test (6MWT), developed for patients with respiratory
diseases, has been used extensively in the elderly [12] and clinical populations [13,14]. Since then,
its validity has been tested in populations of various ages and health status; however, conflicting
results have been reported [15–18]. Furthermore, whether the 6MWT is valid in estimating VO2max in
relatively young and healthy populations remains unclear. Although single-stage step tests and the
6MWT have been validated previously, they have not been validated in comparison with each other
and against actual measured VO2max in the same participants. Therefore, this study aimed to test the
validity of three different submaximal tests (i.e., 3MST20, 3MST30, and 6MWT) in estimating VO2max in
young and healthy individuals.
2. Materials and Methods
2.1. Study Sample
Seventy-three healthy adults (37 men and 36 women; mean age: 30.8 ± 9.3 years, weight:
68.3 ± 13.9 kg, height: 168.2 ± 10.5 cm) were recruited from the university and Community Service
Center at Yonsei University via advertising posters on bulletin boards from March 2013 to March 2014.
Participants were screened for cardiopulmonary, orthopedic, and musculoskeletal conditions prior
to testing using the Physical Activity Readiness Questionnaire and participant self-reported health
history [19]. All participants provided written informed consent after explanation of experimental
procedures and possible risks and benefits. The study was approved by the Institutional Review Board
(IRB) of Severance Hospital, Yonsei University College of Medicine (IRB number: 4-2013-0345).
2.2. Experimental Protocol
The experimental protocol consisted of three clinical visits. During their first visit, anthropometric
variables, such as height, weight, waist circumference, blood pressure, resting heart rate (RHR), and
VO2max were measured. All participants were randomly categorized into two groups (groups A and
B) to avoid order effects. The participants in group A underwent the 3MST20 on their second visit
and 3MST30 on their third visit; those in group B underwent the tests in reverse order. The third visit
was scheduled 3 to 7 days after the second visit at the same hour of the day to minimize the effects
circadian rhythm of the heart rate. All measurements were performed by the same investigator in
a quiet and air-conditioned laboratory (temperature, 18–22 ◦C; humidity, 40–60%). The participants
were asked to maintain their daily living activities as usual. However, they were asked to refrain from
strenuous exercise for 24 h, drinking alcohol and caffeine for 4 h, and eating or drinking (except water)
for 2 h before the test.
Int. J. Environ. Res. Public Health 2019, 16, 4858 3 of 10
2.3. Step Tests
Step tests were conducted using the following standardized procedure. First, participants were
fitted with a wearable heart rate monitor (Polar, FT1, Kempele, Finland) and then sat in a chair until a
steady-state RHR was achieved (i.e., less than 5 beat-per-minute change in heart rate for one minute.
Then, participants continuously stepped onto and off the box 24 times per minute for 3 min while heart
rate was recorded every minute. Stepping rate was synchronized to a metronome set at 96 beats per
minute and monitored throughout testing. Finally, after 3 min of stepping, participants immediately
sat down in a chair while heart rate recovery was monitored for 1 min.
2.4. 6MWT
The 6MWT was conducted according to standardized procedures provided by the American
Thoracic Society [14]. It was conducted in an indoor corridor, and the course was marked by two green
corns placed 30 m apart. Prior to the test, the examiner demonstrated the walking form and provided
notifications of foul (both feet off the ground). There was no warm-up or practice beforehand. The
participants rested for at least 5 min while sitting on a chair located near the starting position. They
were asked to walk at their maximal pace to cover as much ground as possible over a 6-min period.
Standardized encouragement (“keep going,” “you are doing well,” and “everything is going fine”)
was provided by the examiner during the test; other words were not allowed. The walking distance
covered in meters after 6 min was recorded.
2.5. Cardiopulmonary Exercise Test (CPET)
CPET to measure VO2max was conducted on a treadmill using a computerized cardiac stress testing
system (Cardiac Science, Q-stress TM65, Waukesha, WI, USA). The participants underwent 12-lead
electromyography to monitor their heart rate and cardiopulmonary stability and wore a non-rebreathing
facemask (Hans Rudolph, Rudolph series 7910, Kansas, MO, USA). Oxygen consumption was
continuously measured breath-by-breath using a computerized metabolic measurement system
(ParvoMedics, TrueOne 2400, Sandy, UT, USA). Borg rating of perceived exertion (RPE) scale was
noted every 2-min. The participants walked for a minute (speed, 1 mph; grade, 0%) prior to the test
as warm-up and familiarization to the treadmill. A well-trained investigator followed the modified
Bruce protocol. VO2max was considered achieved if any two of the following three criteria were met:
(1) Respiratory exchange ratio of ≥1.1; (2) heart rate of >90% of age-predicted maximal heart rate; and
(3) RPE of ≥18. The age-predicted maximal heart rate (APMHR) was calculated using the following
formula: (208− (0.7× age)) [20]. All participants satisfied at least two of the VO2max criteria and were
then included in the analysis.
2.6. Statistical Analysis
The statistical significance level in all tests was set at p < 0.05, and all analyses were performed
using SPSS 25 for Windows (SPSS Inc., Chicago, IL, US). All data were presented as means ± standard
deviations. Correlation analyses were performed to assess the relationship between directly measured
VO2max, anthropometric measurements, and outcome measures from the step tests and 6MWT.
Multiple linear regressions were used to construct the VO2max prediction equation to estimate VO2max
using variables gained from the step tests and 6MWT. In the main analysis, we used data from all
participants for both model building and validation. In the sensitivity analyses, data-splitting was
performed randomly to create three groups. Thereafter, model-building (two-third of the tests) and
model-validation data sets (one-third of the tests) were developed. The same process was repeated
two more times. Paired t-test was used to assess agreement between the estimated and actual VO2max.
Scatter plots and Bland–Altman plots were constructed to compare the predicted and directly measured
VO2max; limits of agreement were set to ± 1.96 standard deviations from the mean.
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3. Results
The study population was comprised of 37 men and 36 women; participant characteristics are
reported in Table 1. Among 73 participants, 64 participants completed all tests: Two step tests, 6MWT,
and VO2max test. The 3MST20 was not assessed in 6 participants due to conflict of schedule and 6MWT
was not assessed in 9 participants due to knee condition or conflict of schedule.
Table 1. Characteristics of participants.
Variables All Men Women
N 73 37 36
Age (year) 30.8 (9.3) 29.4 (9.5) 32.3 (8.9)
Weight (kg) 68.3 (13.9) 76.7 (11.5) 59.7 (10.7) *
Height (cm) 168.2 (10.5) 175.9 (7.7) 160.3 (6.2) *
BMI (kg/m2) 24.2 (3.7) 24.7 (2.7) 23.6 (4.5)
Waist circumference (cm) 81.8 (11.1) 85.4 (9.1) 78.0 (11.8) *
Resting heart rate (bpm) 66.2 (9.4) 63.2 (10.2) 69.2 (7.6) *
SBP (mmHg) 118.7 (13.4) 127.0 (11.9) 110.1 (8.8) *
DBP (mmHg) 75.2 (9.4) 77.0 (9.1) 73.3 (9.6)
Note: BMI = body mass index; bpm = beats per minute; SBP = systolic blood pressure; DBP = diastolic blood
pressure. Data are presented as means (standard deviations). * Significant differences from men, p < 0.05.
As shown in Table 2, heart rate increased up to 108.2 ± 9.8 bpm (57.7% APMHR) and
125.3 ± 14.5 bpm (67.8% APMHR) at the third minute of the 3MST20 in the male and female participants,
respectively; conversely, the heart rate increased up to 125.3 ± 10.9 bpm (67.0% APMHR) and
150.0 ± 14.6 bpm (81.1% APMHR) at the third minute of the 3MST30, respectively. The measured VO2max
value was 42.8 ± 7.3 and 31.6 ± 6.3 mL·kg−1·min−1 in the male and female participants, respectively.
Table 2. The results of maximal and submaximal tests.
Heading All Men Women
3MST20 N = 66 N = 33 N = 33
RHR (bpm) 68.9 (9.7) 66.2 (11.0) 71.6 (7.4) *
HR1 (bpm) 109.5 (12.6) 103.6 (10.1) 115.4 (12.3) *
HR2 (bpm) 114.1 (14.6) 105.8 (9.5) 122.6 (14.3) *
HR3 (bpm) 116.7 (15.0) 108.2 (9.8) 125.3 (14.5) *
HRR30s (bpm) 94.1 (15.1) 86.2 (11.4) 101.9 (14.2) *
HRR1 (bpm) 81.1 (13.9) 74.8 (12.2) 87.4 (12.2) *
%APMHR at the third minute of exercise 62.8 (8.7) 57.7 (5.9) 67.8 (8.2) *
3MST30 N = 73 N = 37 N = 36
RHR (bpm) 70.7 (10.7) 67.4 (10.3) 74.1 (10.2) *
HR1 (bpm) 121.6 (13.2) 114.3 (8.6) 129.1 (12.9) *
HR2 (bpm) 132.9 (15.6) 122.3 (10.4) 143.8 (12.2) *
HR3 (bpm) 137.5 (17.8) 125.3 (10.9) 150.0 (14.6) *
HRR30s (bpm) 112.9 (20.5) 101.9 (14.9) 124.3 (19.4) *
HRR1 (bpm) 96.5 (20.4) 86.1 (15.0) 107.1 (19.8) *
%APMHR at the third minute of exercise 73.9 (10.8) 67.0 (7.2) 81.1 (9.0) *
Six-minute walk test N = 64 N = 32 N = 32
Distance (m) 715 (94.9) 762.7 (97.2) 667.4 (64.6) *
Cardiopulmonary exercise test N = 73 N = 37 N = 36
RHR (bpm) 19.01 (1.1) 19.0 (1.0) 19.0 (1.2)
HR at end of the test (bpm) 188.8 (10.3) 191.6 (8.7) 185.9 (11.2) *
%APMHR 101.3 (5.5) 102.3 (5.0) 100.3 (5.8)
Cessation stage (range) 5.2 (3–6) 5.7 (5–6) 4.6 (3–6)
VO2max (mL·kg−1·min−1) 37.3 (8.8) 42.8 (7.3) 31.6 (6.3) *
Note: 3MST20 = 3-min step test using 20.3-cm step box height; RHR = resting heart rate; bpm = beats per minute;
HR1 = heart rate at 1 min; HR2 = heart rate at 2 min; HR3 = heart rate at 3 min; HRR30s = heart rate recovery at 30 s
after cessation; HRR1 = heart rate recovery at 1 min after cessation; APMHR = age-predicted maximal heart rate;
3MST30 = 3-min step test using 30-cm step box height; HR = heart rate; VO2max = maximal oxygen consumption.
Numerical variables are presented as means (standard deviations) and categorical variables as means (ranges).
* Significant differences from the male participants, p < 0.05.
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We performed correlation analyses to determine the association between step test heart rate
recovery measures and directly measured VO2max (Supplementary Table S1). In both the 3MST20 and
3MST30, heart rate recovery at 30 s (HRR30s) showed the strongest correlation with the measured
VO2max (Supplementary Table S1); therefore, it was used for the VO2max estimation model. The HRR30s
attributed to the 32.8% of VO2max and 45.8% of VO2max for the 3MST20 and 3MST30, respectively.
When the HRR30s was complemented with sex, age, and weight, the model showed 73.4% and 72.2%
of VO2max, for 3MST20 and 3MST30 respectively. The distance walked during the 6MWT attributed
to 44.1% of VO2max, which increased to 74.4% when sex, age, and weight were added to the model
(Table 3).
Table 3. Prediction equation model development using the different submaximal tests.
Tests Models Adjusted
R2
SEE ∆F
Coefficient Estimates
Intercept HRR30s Sex Age Weight Distance
Walked·10−1
3MST20
Model 1 0.328 7.4 36.7 * 69.9 * −12.0 *
Model 2 0.503 6.4 33.9 * 68.5 * −0.2 * −9.0 *
Model 3 0.713 4.9 54.7 * 76.4 * −0.1 * −8.0 * −0.5 *
Model 4 0.734 4.7 45.9 * 86.0 * −0.1 * −10.9 * −0.4 * −0.1 *
3MST30
Model 1 0.458 6.5 61.9 * 70.5 * −0.3 *
Model 2 0.555 5.9 45.9 * 70.3 * −0.2 * −6.7 *
Model 3 0.699 4.8 56.8 * 73.7 * −0.1 * −7.6 * −0.4 *
Model 4 0.722 4.7 47.7 * 84.5 * −0.1 * −10.2 * −0.4 * −0.1 *
6MWT
Model 1 0.441 6.8 50.8 * −9.09 0.6 *
Model 2 0.576 5.9 43.8 * 17.6 * −7.8 * 0.4 *
Model 3 0.699 5.0 49.7 * 45.7 * −8.2 * −0.4 * 0.2 *
Model 4 0.744 4.6 46.8 * 61.1 * −11.2 * −0.4 * −0.2 * 0.2 *
Note: SEE = standard error of estimate; HRR30s = heart rate recovery at 30 s; 3MST20 = 3-min step test using 20-cm
step height; 3MST30 = 3-min step test using 30-cm step height; 6MWT = 6-min walk test. * p < 0.05.
Thereafter, we used multiple linear regressions to develop the prediction equation for VO2max
estimation for each of the submaximal tests.
• 3MST20: VO2max = 86.0 − 10.9 × sex (male = 1, f emale = 2) − 0.4 × age − 0.1 × weight − 0.1 ×
HRR30s
• 3MST30: VO2max = 84.5 − 10.2 × sex (male = 1, f emale = 2) − 0.4 × age − 0.1 × weight −
0.1 × HRR30s
• 6MWT: VO2max = 61.1 − 11.1 × sex (male = 1, f emale = 2) − 0.4 × age − 0.2 × weight −
0.2 ×
(
distance walked·10−1
)
Using these equations, we calculated VO2max for each participant. The estimated VO2max values
were 37.0 ± 7.9, 37.3 ± 7.6, and 36.9 ± 7.9 mL·kg−1·min−1 derived from the 3MST20, 3MST30, and 6MWT,
respectively; the R2 values between the estimated and measured VO2max were 0.734, 0.722, and 0.744,
respectively (Figure 1).
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Figure 1. Correlations between measured VO2max and model-predicted VO2max using 2MST20 (r = 0.866
p < 0.05) (A), 3MST30 (r = 0.859, p < 0.05) (B), and 6MWT (r = 0.872, p < 0.05) (C).
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There were no significant differences between the predicted and directly measured VO2max values.
Furthermore, the Bland–Altman plot analysis showed no notable difference in the agreement between
the estimated and measured VO2max according to sex in all three submaximal tests (Figure 2).
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Since data from same participants were used for building the prediction equation and validation,
we performed further sensitivity analyses using three-fold cross validation methods; the participants
in two groups were used to develop the prediction equation and participants in one group to validate
the estimated results. The same methods were repeated three times (Supplementary Tables S2–S4
and Figures S1–S3), and the results were similar to those in our main analyses. The adjusted R2 value
between the estimated VO2max using the three different estimation equations from the 3MST20 and
measured VO2max ranged from 0.702 to 0.773. The adjusted R2 value between the estimated VO2max
using the three different estimation equations from the 3MST30 and measured VO2max ranged from
0.661 to 0.803. The adjusted R2 value between the estimated VO2max using the three different estimation
equations from the 6MWT and measured VO2max ranged from 0.700 to 0.820.
4. Discussion
As cardiopulmonary fitness is often used to predict health status, mortality and the prevalence or
incidence of diseases [1], safe, convenient, and valid measurement to assess such is of great interest for
epidemiological studies. In our study, we have demonstrated that two steps tests (3MST20, 3MST30) as
well as the 6MWT were valid method in estimating VO2max in relatively young and healthy population.
We also confirmed that the 3MST20 was not inferior to the 3MST30 in estimating VO2max, suggesting
that a lower step height is as good as a higher step height.
Owing to its convenience, many step test protocols have been developed and validated [2,7,10,21].
In incremental step tests, participants’ ability to perform incremental work and physiological response
to the work are usually observed [4]; the step height, test duration, stepping rate, RPE, and heart
rate response during the test and/or recovery are also considered. However, these tests have several
assumptions: Participants’ will to complete the tests, validity and reliability of the RPE, and validity of
the APMHR. Thus, the step test protocol, which eliminates these assumptions from the test, might be
more valid. In this context, we validated relatively short (3 min) and single-stage (fixed step height
and stepping rate) step tests. As the step height significantly influences the participants’ ability to
complete the test owing to possible presence of local muscle fatigue, lower extremity joint pain, and
physical function impairment, we tested two different 3-min step test protocols at 20.3 and 30 cm,
conducted on separate days in random order. As expected, the heart rate increase was higher during
the step test using higher step height was used. However, we found no difference in the validity of the
two different protocols in estimating VO2max, suggesting that the 3MST20 is as good as the 3MST30 in
estimating VO2max.
Int. J. Environ. Res. Public Health 2019, 16, 4858 7 of 10
Demonstrating the 3MST20 is not inferior to the 3MST30 is of interest for several reasons. Owing
to the lower step height, the 3MST20 is more feasible for those with lower extremity joint problems,
obese and unfit individuals. Previously, Bohannon et al. [11] compared between the 6MWT and YMCA
step test and found relatively low completion rates in the latter; 51 out of 189 participants did not
complete the test. The average age of those who did not complete the step test was 70.4 ± 14.2 years,
while that of those who completed the test was 39.9 ± 19.4 years. Similarly, Beutner et al. [2] also
reported that 17% of their participants did not complete 3 min YMCA step test; participants who were
not able to complete the 3 min tests were older (53.2 vs. 69.3 years) and more obese (BMI: 24.5 vs.
29.5 kg/m2). As most study populations had a wide range of age and health status, we can speculate
that the 3MST20, which uses a lower step height, would be more feasible. Furthermore, our study
showed that the 3MST20 and 3MST30 increased the heart rate up to 62.8% and 73.9% of the APMHR,
respectively. In the female participants, the heart rate increased up to 81.1% of their APMHR during
the 3MST30, which suggests that the 3MST30 is a moderate to vigorous intensity exercise. Therefore,
the 3MST20 can be more suitable for those with potential risks of cardiac events. However, we did not
validate the 3MST20 for prediction of VO2max in clinical populations in our study.
One of the strengths of single-stage step tests is the lack of influence by the will of participants,
especially with shorter durations (e.g., 3 min) and lower step heights. The heart rate only increased
up to 60–70% of the APMHR during the 3MST20, which suggests relatively low physical stress to the
participants during the test. As participants cannot manipulate their own heart rate, the 3MST20 using
heart rate recovery after submaximal exercise may yield objective results. In this context, single-stage
step tests with lower step heights rather than multi-stage step tests may be more reliable. For example,
the Chester step test lasts up to 10 min and uses a 30-cm step box with an incremental stepping
rate [4,7]; it ends when participants (1) cannot continue the test, (2) have reached 80% of their APMHR,
and (3) have reached 10 min into the test. Therefore, single-stage 3-min step tests with low step heights,
such as the Tecumseh step test, might be a safe, objective, inexpensive, convenient, and valid test to
assess the level of aerobic fitness.
Although both the 3MST20 and 3MST30 were valid in estimating VO2max, it is important to note
that the prediction equations also included other variables, such as age, sex, and body weight. When
only HRR30s during the 3MST20 and 3MST30 was used as a predicting variable, a stronger correlation
was observed between the HRR30s and actual VO2max during 3MST30. When the prediction equation
was supplemented with age, sex, and body weight, the prediction equation developed for both step
tests explained the actual VO2max to an equal extent.
Our study also validated the 6MWT in estimating VO2max. In 1968, Cooper developed and
validated a 12-min run test to estimate VO2max in male US Air Force officers and personnel [22]. Later,
McGavin et al. [23] modified this test as a 12-min walk test to assess lung function among patients with
chronic bronchitis, which later became the 6-min walk test (3MWT) [24]. Since then, the 6MWT has
been validated in various clinical populations [25], including those with cancer [26,27], although a
recent study did not recommend the use of the 6MWT to assess VO2max in patients with cancer [28]. In
the current study, the 6MWT was also valid in estimating VO2max of the relatively young and healthy
participants. The VO2max estimated using the prediction equation derived from the 6MWT agrees with
the actual VO2max (36.8 vs. 36.9 mL·kg−1·min−1). When the model-building and model-validation
sets were randomly assigned, the estimated VO2max in the 6MWT was still valid, with a correlation
coefficient between 0.771 and 0.910.
Our study has strengths and limitations. One of the strengths of our study is that three different
submaximal tests were validated in estimating VO2max against the measured VO2max among the same
participants. Furthermore, we provided evidence that the use of short-duration step tests using a low
step box (20.3 cm), which elicited a significantly lower heart rate than the step test using a high step
box, is equally valid in estimating VO2max in young and healthy populations. Traditionally, a good step
test encourages higher steps, higher stepping rates, and longer durations; which mimics the maximal
test. However, we clearly demonstrated that submaximal tests using heart rate or distance walked in
Int. J. Environ. Res. Public Health 2019, 16, 4858 8 of 10
6 min were sufficient in estimating VO2max in healthy populations. Conversely, our study limitation is
the relatively small convenience sample from a university and community service center in Korea;
therefore, the participants were generally young and healthy Koreans. Thus, caution should be taken
in applying our results to the elderly, clinical populations, and other ethnicities. Another limitation is
the use of the same sample for model building and validation in estimating VO2max. To overcome
this limitation, we performed sensitivity analyses by randomly splitting our sample into three groups
and cross-validating them. These analyses showed that our submaximal tests were all still valid in
estimating VO2max. Further research with a broader range of populations will, however, be required to
enhance the validity of the prediction equations of the tests.
5. Conclusions
We validated the 3-min step test using two different step box heights and the 6MWT in a relatively
young and healthy Asian population; these tests can be used to provide valid estimates of VO2max in
epidemiological studies.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/16/23/4858/s1,
Figure S1: Correlations between the measured VO2max and model-predicted VO2max in the 3-min step test using
a 20-cm step height. The prediction equation model was developed using randomly selected two-third of the
participants, and their value was compared with that of the non-selected one-third of the participants. The same
methods were repeated three times, Figure S2: Correlations between the measured VO2max and model-predicted
VO2max in the 3-min step test using a 30-cm step height. The prediction equation model was developed using
randomly selected two-third of the participants, and their value was compared with that of the non-selected
one-third of the participants. The same methods were repeated three times, Figure S3: Correlations between the
measured VO2max and model-predicted VO2max in the 6-min walk test. The prediction equation model was
developed using randomly selected two-third of the participants, and their value was compared with that of the
non-selected one-third of the participants. The same methods were repeated three times, Table S1: Correlation
between the measured VO2max, anthropometrics, and variables acquired from the submaximal tests, Table S2:
Correlations between the measured VO2max and model-predicted VO2max in the 3-min step test using a 20-cm
step height. The prediction equation model was developed using randomly selected two-third of the participants,
and their value was compared with that of the non-selected one-third of the participants. The same methods were
repeated three times, Table S3: Correlations between the measured VO2max and model-predicted VO2max in
the 3-min step test using a 30-cm step height. The prediction equation model was developed using randomly
selected two-third of the participants, and their value was compared with that of the non-selected one-third of
the participants. The same methods were repeated three times, Table S4: Correlations between the measured
VO2max and model-predicted VO2max in the 6-min walk test. The prediction equation model was developed
using randomly selected two-third of the participants, and their value was compared with that of the non-selected
one-third of the participants. The same methods were repeated three times.
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